Every material Form 8-K abrdn Healthcare Investors filed with the SEC in 2013, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
H&Q Healthcare Investors, a closed-end fund listed on the NYSE as HQH, said its Board of Trustees renewed its share repurchase program. The renewal lets the fund buy back up to 12% of its outstanding common shares in the open market for a one-year period ending July 10, 2014, replacing the current program that ends July 10, 2013. The Board said the goal is to reduce the discount between the share price and net asset value per share, though the filing gives no assurance of any specific repurchase amount or discount level.
Renewed program allows open-market purchases of up to 12% of outstanding common shares
Current program runs through July 10, 2013; renewal extends the period to July 10, 2014
Timing and amount of repurchases are at the discretion of Tekla Capital Management LLC, the fund's investment adviser
The filing states there is no assurance that repurchases will narrow the discount or raise the share price
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every abrdn Healthcare Investors filing is on SEC EDGAR ↗. 8-K briefs of other companies →